Get started
Source

NeuroImmune Pharmacology and Therapeutics

ISSN: 2750-6665
Source type: journal
Fully OA: No
DOAJ: No
Article Processing Charge: $1,695
OpenAlex ID: S4387280666
The elusive role of herpesviruses in Alzheimer’s disease: current evidence and future directions
2023 · Stacey L. Piotrowski, Allison Tucker, et al. · NeuroImmune Pharmacology and Therapeutics · 24
PDF
Abnormal brain diffusivity in participants with persistent neuropsychiatric symptoms after COVID-19
2023 · Huajun Liang, Thomas Ernst, et al. · NeuroImmune Pharmacology and Therapeutics · 21
PDF
Ongoing oxidative stress in individuals with post-acute sequelae of COVID-19
2022 · Muhammad G. Saleh, Linda Chang, et al. · NeuroImmune Pharmacology and Therapeutics · 21
PDF
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
2022 · Milica Markovic, Pravin Yeapuri, et al. · NeuroImmune Pharmacology and Therapeutics · 21
PDF
Mu opioid receptor-mediated release of endolysosome iron increases levels of mitochondrial iron, reactive oxygen species, and cell death
2022 · Peter W. Halcrow, Nirmal Kumar, et al. · NeuroImmune Pharmacology and Therapeutics · 15
PDF
Quantifying the neuropsychiatric symptoms in post-acute sequelae of COVID-19 (PASC) using the NIH Toolbox ® and PROMIS
2022 · Meghann Ryan, Huajun Liang, et al. · NeuroImmune Pharmacology and Therapeutics · 13
PDF
The role of tunneling nanotubes during early stages of HIV infection and reactivation: implications in HIV cure
2023 · Silvana Valdebenito, Akira Ono, et al. · NeuroImmune Pharmacology and Therapeutics · 11
PDF
Blood-brain barrier breakdown in COVID-19 ICU survivors: an MRI pilot study
2023 · Wen Shi, Dengrong Jiang, et al. · NeuroImmune Pharmacology and Therapeutics · 10
PDF
Activation of CB2R by synthetic CB2R agonist, PM289, improves brain endothelial barrier properties, decreases inflammatory response and enhances endothelial repair
2023 · Trent A. Bullock, Kalpani N. Udeni Galpayage Dona, et al. · NeuroImmune Pharmacology and Therapeutics · 10
PDF
Immune senescence in aged APP/PS1 mice
2023 · Mai M. Abdelmoaty, Pravin Yeapuri, et al. · NeuroImmune Pharmacology and Therapeutics · 10
PDF
Weak base drug-induced endolysosome iron dyshomeostasis controls the generation of reactive oxygen species, mitochondrial depolarization, and cytotoxicity
2024 · Peter W. Halcrow, Darius N. K. Quansah, et al. · NeuroImmune Pharmacology and Therapeutics · 9
PDF
Mechanisms of Zika astrocyte infection and neuronal toxicity
2022 · Courtney Veilleux, Eliseo A. Eugenin · NeuroImmune Pharmacology and Therapeutics · 9
PDF
Meta-analysis of the effects of palmitic acid on microglia activation and neurodegeneration
2022 · Heping Zhou, Sulie L. Chang · NeuroImmune Pharmacology and Therapeutics · 9
PDF
Cinnamic acid, a natural plant compound, exhibits neuroprotection in a mouse model of Sandhoff disease via PPARα
2024 · Sumita Raha, Ramesh K. Paidi, et al. · NeuroImmune Pharmacology and Therapeutics · 8
PDF
Adaptive immunity in the pathogenesis and treatments of Parkinson’s disease
2025 · Xiaoqing Du, Samia Akter, et al. · NeuroImmune Pharmacology and Therapeutics · 7
PDF
HIV-1 infection facilitates Alzheimer’s disease pathology in humanized APP knock-in immunodeficient mice
2025 · Shaurav Bhattarai, Rana Kadry, et al. · NeuroImmune Pharmacology and Therapeutics · 7
PDF
Sedation with midazolam in the NICU: implications on neurodevelopment
2024 · Nghi M. Nguyen, Gurudutt Pendyala · NeuroImmune Pharmacology and Therapeutics · 7
PDF
X-chromosome linked genes associated with myeloid cell CNS trafficking contributes to female–male differences in the disease outcome for neuroinflammatory diseases
2024 · Sopiko Darchiashvili, Ratuja Kulkarni, et al. · NeuroImmune Pharmacology and Therapeutics · 7
PDF
Virology, pathogenesis, epidemiology and clinical management of HTLV-1 infection. Proceedings of the 30th HTLV European research network (HERN 2023)
2024 · Carmen de Mendoza, Graham Taylor, et al. · NeuroImmune Pharmacology and Therapeutics · 7
PDF
A simple protocol for isolating microglia from adult mouse brain
2023 · Sudipta Chakrabarti, Sukhamoy Gorai, et al. · NeuroImmune Pharmacology and Therapeutics · 7
PDF
Resveratrol and its analogs suppress HIV replication, oxidative stress, and inflammation in macrophages
2023 · Santosh Kumar, Namita Sinha, et al. · NeuroImmune Pharmacology and Therapeutics · 7
PDF
Protection of dopaminergic neurons in hemiparkinsonian monkeys by flavouring ingredient glyceryl tribenzoate
2022 · Suresh B. Rangasamy, Debashis Dutta, et al. · NeuroImmune Pharmacology and Therapeutics · 7
PDF
Neuroprotective mushrooms
2024 · Mai M. Abdelmoaty, Rana Kadry, et al. · NeuroImmune Pharmacology and Therapeutics · 6
PDF
Nebulization of low-dose aspirin ameliorates Huntington’s pathology in N171-82Q transgenic mice
2024 · Susanta Mondal, Shelby Prieto, et al. · NeuroImmune Pharmacology and Therapeutics · 6
PDF
The S1 subunits of SARS-CoV-2 variants differentially trigger the IL-6 signaling pathway in human brain endothelial cells and downstream impact on microglia activation
2024 · Michael Stangis, Daniel Adesse, et al. · NeuroImmune Pharmacology and Therapeutics · 6
PDF
Works count: 117
Citation count: 353
H-index: 10
I10-index: 10
2yr mean citedness: 1.527
Year
Topic
Type